DiaMedica Therapeutics Inc (DMAC)
3.00
+0.37
(+14.07%)
USD |
NASDAQ |
May 03, 16:00
3.005
0.00 (0.00%)
After-Hours: 20:00
DiaMedica Therapeutics Total Liabilities (Quarterly): 3.103M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.103M |
September 30, 2023 | 2.51M |
June 30, 2023 | 2.307M |
March 31, 2023 | 3.195M |
December 31, 2022 | 2.568M |
September 30, 2022 | 1.962M |
June 30, 2022 | 1.543M |
March 31, 2022 | 1.443M |
December 31, 2021 | 1.527M |
September 30, 2021 | 1.628M |
June 30, 2021 | 1.456M |
March 31, 2021 | 1.211M |
December 31, 2020 | 2.081M |
September 30, 2020 | 1.512M |
June 30, 2020 | 1.309M |
March 31, 2020 | 1.042M |
December 31, 2019 | 1.436M |
September 30, 2019 | 1.339M |
June 30, 2019 | 1.095M |
March 31, 2019 | 1.588M |
December 31, 2018 | 1.314M |
September 30, 2018 | 4.079M |
June 30, 2018 | 4.921M |
March 31, 2018 | 3.167M |
December 31, 2017 | 1.003M |
Date | Value |
---|---|
September 30, 2017 | 1.055M |
June 30, 2017 | 1.225M |
March 31, 2017 | 1.064M |
December 31, 2016 | 0.764M |
September 30, 2016 | 1.496M |
June 30, 2016 | 1.471M |
March 31, 2016 | 1.398M |
December 31, 2015 | 1.456M |
September 30, 2015 | 1.345M |
June 30, 2015 | 1.47M |
March 31, 2015 | 1.693M |
December 31, 2014 | 1.812M |
September 30, 2014 | 1.408M |
June 30, 2014 | 1.636M |
March 31, 2014 | 2.280M |
December 31, 2013 | 1.524M |
September 30, 2013 | 0.9628M |
June 30, 2013 | 0.9048M |
March 31, 2013 | 1.688M |
December 31, 2012 | 1.582M |
September 30, 2012 | 0.8202M |
June 30, 2012 | 0.9345M |
March 31, 2012 | 0.756M |
December 31, 2011 | 0.3646M |
September 30, 2011 | 0.4747M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.042M
Minimum
Mar 2020
3.195M
Maximum
Mar 2023
1.804M
Average
1.527M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
NextCure Inc | 13.62M |
NovaBay Pharmaceuticals Inc | 5.72M |
Palatin Technologies Inc | 24.94M |
iBio Inc | 24.82M |
Theriva Biologics Inc | 15.52M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 54.16M |
Shareholders Equity (Quarterly) | 51.06M |